Francesco Paolo Fanizzi Selected Research

Pt(O,O'-acac)(gamma-acac)(DMS)

4/2021	[Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.
2/2015	Renal fibrogenesis and platinum compounds in a rat model: a novel Pt (II) complex vs. cisplatin.
7/2010	Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Paolo Fanizzi Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2011
6	Breast Neoplasms (Breast Cancer) 05/2019 - 07/2010
5	Neuroblastoma 01/2022 - 01/2014
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2020
2	Disease Progression 01/2022 - 05/2019
2	Glioma (Gliomas) 04/2021 - 04/2021
2	Infections 07/2019 - 04/2019
2	Malaria 11/2012 - 03/2012
1	Glioblastoma (Glioblastoma Multiforme) 04/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Vibrio Infections 05/2019
1	Hyperglycemia 05/2019
1	Type 2 Diabetes Mellitus (MODY) 05/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2019
1	Carcinoma (Carcinomatosis) 05/2019
1	Dehydration (Water Stress) 05/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Ovarian Epithelial Carcinoma 09/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2018
1	Ototoxicity 05/2016
1	Hypertrophy 01/2016
1	Necrosis 01/2016
1	Malignant Mesothelioma 01/2016
1	Atrophy 02/2015
1	Neoplasm Metastasis (Metastasis) 07/2010

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
3	PlatinumIBA 01/2022 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2019
3	Pt(O,O'-acac)(gamma-acac)(DMS)IBA 04/2021 - 07/2010
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2019
3	Biological ProductsIBA 05/2019 - 01/2011
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2022 - 01/2022
2	Platinum Compounds (Compounds, Platinum)IBA 04/2021 - 02/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 05/2019
2	acetyl acetonate (acetylacetonate)IBA 11/2014 - 01/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 07/2010
1	PhenanthrolinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	ethyl acetateIBA 01/2021
1	MetalsIBA 06/2019
1	CarbohydratesIBA 05/2019
1	LipidsIBA 05/2019
1	Human Serum Albumin FDA LinkGeneric 05/2019
1	Calcium Carbonate (Limestone)FDA Link 05/2019
1	Protein CoronaIBA 05/2019
1	malic acid (malate)IBA 04/2019
1	CaspasesIBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2019
1	EnzymesIBA 01/2019
1	dactolisibIBA 01/2018
1	Capsules (Microcapsules)IBA 06/2017
1	ElementsIBA 02/2016
1	Carisoprodol (Soma)FDA LinkGeneric 02/2015
1	dimethyl sulfideIBA 11/2014
1	platinum(II) 2,4-pentanedionateIBA 01/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2014
1	TeaIBA 11/2012
1	Antimalarials (Antimalarial Agents)IBA 03/2012
1	CalciumIBA 01/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2021 - 01/2016
1	Therapeutics 10/2020
1	Nephrectomy 01/2016